Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$7.45 - $12.83 $2.09 Million - $3.59 Million
-280,168 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.75 - $14.44 $3.04 Million - $4.51 Million
-311,988 Reduced 52.69%
280,168 $3.04 Million
Q4 2021

Feb 14, 2022

SELL
$13.17 - $20.94 $725,469 - $1.15 Million
-55,085 Reduced 8.51%
592,156 $8.33 Million
Q3 2021

Nov 15, 2021

BUY
$9.16 - $19.83 $5.77 Million - $12.5 Million
630,244 Added 3707.97%
647,241 $12.4 Million
Q2 2021

Aug 16, 2021

SELL
$7.25 - $10.99 $326,547 - $495,000
-45,041 Reduced 72.6%
16,997 $167,000
Q1 2021

May 17, 2021

BUY
$4.57 - $11.18 $283,513 - $693,584
62,038 New
62,038 $610,000
Q3 2020

Nov 16, 2020

SELL
$4.32 - $11.7 $70,848 - $191,880
-16,400 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.94 - $9.1 $48,216 - $149,240
16,400 New
16,400 $145,000
Q2 2019

Aug 14, 2019

SELL
$3.65 - $7.89 $269,351 - $582,242
-73,795 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$7.08 - $12.09 $522,468 - $892,181
73,795 New
73,795 $539,000
Q4 2017

Feb 14, 2018

SELL
$17.3 - $24.08 $1.15 Million - $1.6 Million
-66,448 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $1.01 Million - $1.43 Million
66,448
66,448 $1.43 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.